scispace - formally typeset
S

Shuichiro Nakabo

Researcher at National Institutes of Health

Publications -  34
Citations -  988

Shuichiro Nakabo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Rheumatoid arthritis & Systemic lupus erythematosus. The author has an hindex of 10, co-authored 30 publications receiving 401 citations. Previous affiliations of Shuichiro Nakabo include Kyoto University.

Papers
More filters
Journal ArticleDOI

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

TL;DR: Using a genotype-driven approach, this disorder is identified that connects seemingly unrelated adult-onset inflammatory syndromes and is named the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.
Journal ArticleDOI

Sex differences in neutrophil biology modulate response to type I interferons and immunometabolism

TL;DR: It is reported that healthy young adult females have an activated/mature neutrophil profile characterized by enhanced type I IFN pathway activity, enhanced proinflammatory responses, and distinct bioenergetics, and it is shown that these differences are cell specific and likely driven by sex hormones.
Journal ArticleDOI

Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

TL;DR: Evidence is presented that interferon lambda is pathogenic and has nonredundant functions in TLR7-associated lupus inflammation, and it is found that interFERon lambda promotes systemic immune dysregulation through localized effects in the skin and kidneys.
Journal ArticleDOI

Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.

TL;DR: In insights about the mechanisms by which the risk residues interact with each other to produce autoantibodies and are involved in SLE pathophysiology, this work identified novel SLE signals in HLA Class I loci (HLA-A, HLA-B), and localized primary Class II signals to five residue-autoantibody association.